Stifel Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-6,071
| Closed | -$357K | – | 3461 |
|
2023
Q4 | $357K | Sell |
6,071
-21,044
| -78% | -$1.24M | ﹤0.01% | 2746 |
|
2023
Q3 | $1.18M | Buy |
27,115
+5,182
| +24% | +$226K | ﹤0.01% | 1933 |
|
2023
Q2 | $792K | Buy |
21,933
+902
| +4% | +$32.6K | ﹤0.01% | 2226 |
|
2023
Q1 | $782K | Sell |
21,031
-4,218
| -17% | -$157K | ﹤0.01% | 2228 |
|
2022
Q4 | $1.14M | Buy |
25,249
+12,914
| +105% | +$585K | ﹤0.01% | 1897 |
|
2022
Q3 | $861K | Sell |
12,335
-70
| -0.6% | -$4.89K | ﹤0.01% | 2073 |
|
2022
Q2 | $833K | Buy |
12,405
+5,983
| +93% | +$402K | ﹤0.01% | 2135 |
|
2022
Q1 | $528K | Buy |
+6,422
| New | +$528K | ﹤0.01% | 2545 |
|
2021
Q4 | – | Sell |
-1,224
| Closed | -$217K | – | 3497 |
|
2021
Q3 | $217K | Buy |
+1,224
| New | +$217K | ﹤0.01% | 3092 |
|
2021
Q1 | – | Sell |
-1,111
| Closed | -$244K | – | 3309 |
|
2020
Q4 | $244K | Buy |
+1,111
| New | +$244K | ﹤0.01% | 2712 |
|
2019
Q3 | – | Sell |
-3,628
| Closed | -$375K | – | 2998 |
|
2019
Q2 | $375K | Buy |
+3,628
| New | +$375K | ﹤0.01% | 2355 |
|
2018
Q4 | – | Sell |
-5,000
| Closed | -$236K | – | 2836 |
|
2018
Q3 | $236K | Buy |
+5,000
| New | +$236K | ﹤0.01% | 2488 |
|